Is there a need for a national or a global apheresis registry? (Q47663629)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941358%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Is there a need for a national or a global apheresis registry? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941358%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941358%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Jean-Michel Korach

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941358%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Rut Norda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941358%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Gail Rock

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941358%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Fouad Fadel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941358%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941358%20AND%20SRC:MED&resulttype=core&format=json

Transfusion and Apheresis Science

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941358%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941358%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941358%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

179-185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941358%20AND%20SRC:MED&resulttype=core&format=json

1991 registry of the French Society of Hemapheresis (SFH): preliminary results for the first year of the on-line computer access file. The Registry Study Group.

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

International forum: France. The national survey of plasma exchange and therapeutic cytapheresis in France

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Role of replacement fluids in the immediate complications of plasma exchange. French Registry Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Apheresis registry in France: indications, techniques, and complications. French Registry Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Complications of plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Therapeutic apheresis in Canada. The Canadian Apheresis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Canadian Apheresis Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

The use of plasma as a replacement fluid in plasma exchange. Canadian Apheresis Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

The Canadian experience using plasma exchange for immune thrombocytopenic purpura. Canadian Apheresis Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Therapeutic plasma exchange: an update from the Canadian Apheresis Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

The Canadian Apheresis Group and therapeutic plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Apheresis registry in Sweden: scope, techniques and indications for treatment. A report from the Swedish apheresis study group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Present status of therapeutic apheresis in Japan: survey report. (Survey Subcommittee, Scientific Committee, Japanese Society for Apheresis).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

National survey of hemapheresis practice in Turkey (1998).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Frequency of immediate adverse effects associated with apheresis donation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Frequency of immediate adverse effects associated with therapeutic apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Severe infections in plasmapheresis-treated systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Plasmapheresis in the treatment of glomerulonephritis: indications and complications

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Clinically relevant hypokalaemia, hypocalcaemia, and loss of hemoglobin and platelets during stem cell apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

The International Apheresis Registry: results of 1983 second pilot.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Summary of results of 1991 ASFA apheresis survey. American Society for Apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Plasma exchange as rescue therapy in multiple organ failure including acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Adverse events and problems in therapeutic hemapheresis. A report from the Swedish registry.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

The effects of hydroxyethyl starches of varying molecular weights on platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality management.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Is there a place for LDL-apheresis in non-homozygous patients?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900145-9

7 January 2021

10.1016/S1473-0502(03)00145-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941358%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference